Ginseng has been used in traditional medicine for centuries as a supposed longevity enhancer, but robust clinical evidence in humans is scarce. This exploratory study aimed to test whether Panax ginseng Meyer supplementation could influence two key cellular aging markers: telomere length (shorter telomeres are associated with aging) and NAD+/NADH ratio (important for cellular energy metabolism). The researchers enrolled 50 overweight adults aged 45–50 and split them into two groups: a high-dose short-term cohort (6 g/day for 7 days, n=20) and a low-dose long-term cohort (3 g/day for 28 days, n=30). They measured telomere length, NAD+ metabolism, and several secondary markers including oxidative stress (ROS, MDA), inflammation (AGEs), and clinical symptoms (sleep quality, fatigue, erectile function, cognitive symptoms) before treatment, after treatment, and at follow-up.
The results are striking on paper: both groups showed associations with increased telomere length and NAD+/NADH ratio, plus reductions in oxidative stress markers and improvements across all clinical scales measured. The researchers emphasize that these benefits persisted during the 21- or 28-day follow-up period. They conclude that ginseng exerts anti-aging effects by improving cellular biomarkers. However, several critical limitations severely constrain interpretation. First, this is an uncontrolled observational study with no placebo or control arm—participants knew they were receiving ginseng, and without a sham-treatment group, placebo effects (especially for subjective measures like fatigue and sleep) cannot be ruled out. Second, the sample sizes are small (20 and 30 per group), making the findings susceptible to chance variation and outlier effects. Third, the paper is marked as published in February 2026, which is a future date (as of this analysis in 2024), raising questions about the data's authenticity or availability for independent verification.
Another concern is the unusually comprehensive list of positive outcomes across disparate biological systems—telomere biology, NAD+ metabolism, oxidative stress, glycation, lactic acid, sleep quality, cognition, fatigue, and sexual function. While ginseng contains bioactive compounds (ginsenosides) with some experimental anti-inflammatory and antioxidant properties, finding statistically significant improvements across this many unrelated endpoints without adjustment for multiple comparisons is suspicious and suggests either genuine efficacy (unlikely given the lack of mechanism specificity) or selective reporting and/or type I error (false positives). The paper does not report whether multiple-comparison corrections were applied.
The study's transparency is moderate: it appears to be published in a peer-reviewed journal (Journal of Ethnopharmacology, a legitimate specialty journal), but there is no mention of trial registration, open-access data, or conflict-of-interest disclosures. The authors do not specify whether the ginseng product was provided by a commercial entity, which would be a material conflict. Finally, this is a hypothesis-generating exploratory study, meaning the findings are explicitly preliminary and await replication in larger, controlled trials.
For the longevity research field, this study is a reminder that traditional remedies warrant investigation, but extraordinary biological claims require extraordinary evidence. The telomere and NAD+ findings, if real, would be important—but they need replication in a randomized, placebo-controlled trial with adequate sample size and prespecified primary outcomes. Until then, this paper should be viewed as a small, uncontrolled pilot that generates questions rather than answers.
0 Comments
Log in to join the discussion.